Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2022-06-29 15:20 Tx date 2022-06-28 |
$PMN
ProMIS Neurosciences Inc. |
Goldstein, Elliot Paul
4 - Director of Issuer
Direct Ownership
|
Warrants
37 - Stock split or consolidation
|
-466,040 vol |
7,899 | |
Filed 2022-06-29 15:19 Tx date 2022-06-28 |
$PMN
ProMIS Neurosciences Inc. |
Goldstein, Elliot Paul
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-7,816,107 vol |
132,476 | |
Filed 2022-06-29 15:18 Tx date 2022-06-28 |
$PMN
ProMIS Neurosciences Inc. |
Goldstein, Elliot Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-7,284,434 vol |
123,465 | |
Filed 2022-03-01 10:05 Tx date 2022-03-01 |
$PMN
ProMIS Neurosciences Inc. |
Goldstein, Elliot Paul
4 - Director of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
$-34,500
-172,500 vol $0.20 each |
473,939 | |
Filed 2021-03-05 08:06 Tx date 2021-03-05 |
$PMN
ProMIS Neurosciences Inc. |
Goldstein, Elliot Paul
4 - Director of Issuer
Direct Ownership
|
Warrants
36 - Conversion or exchange
|
$41,666
+208,333 vol $0.20 each |
646,439 | |
Filed 2021-03-05 08:05 Tx date 2021-03-05 |
$PMN
ProMIS Neurosciences Inc. |
Goldstein, Elliot Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
+208,333 vol |
7,407,899 | |
Filed 2021-03-05 08:04 Tx date 2021-03-05 |
$PMN
ProMIS Neurosciences Inc. |
Goldstein, Elliot Paul
4 - Director of Issuer
Direct Ownership
|
Special Warrants
36 - Conversion or exchange
|
-208,333 vol |
0 | |
Filed 2020-11-10 15:33 Tx date 2020-11-05 |
$PMN
ProMIS Neurosciences Inc. |
Goldstein, Elliot Paul
4 - Director of Issuer
Direct Ownership
|
Special Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$24,999
+208,333 vol $0.12 each |
208,333 | |
Filed 2020-11-10 15:31 Tx date 2014-09-04 |
$PMN
ProMIS Neurosciences Inc. |
Goldstein, Elliot Paul
4 - Director of Issuer
Direct Ownership
|
Special Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2020-11-10 15:22 Tx date 2014-09-04 |
$PMN
ProMIS Neurosciences Inc. |
Goldstein, Elliot Paul
4 - Director of Issuer
Direct Ownership
|
Special Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2020-11-06 14:48 Tx date 2014-09-04 |
$PMN
ProMIS Neurosciences Inc. |
Goldstein, Elliot Paul
4 - Director of Issuer
Direct Ownership
|
Special Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2020-11-06 14:48 Tx date 2014-09-04 |
$PMN
ProMIS Neurosciences Inc. |
Goldstein, Elliot Paul
4 - Director of Issuer
Direct Ownership
|
Special Warrants
00 - Opening Balance-Initial SEDI Report
|
208,333 | ||
Filed 2020-01-02 07:45 Tx date 2019-12-31 |
$PMN
ProMIS Neurosciences Inc. |
Goldstein, Elliot Paul
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$23,333
+66,666 vol $0.35 each |
438,106 | |
Filed 2020-01-02 07:44 Tx date 2019-12-31 |
$PMN
ProMIS Neurosciences Inc. |
Goldstein, Elliot Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$13,333
+66,666 vol $0.20 each |
7,199,566 | |
Filed 2020-01-02 07:43 Tx date 2019-12-31 |
$PMN
ProMIS Neurosciences Inc. |
Goldstein, Elliot Paul
4 - Director of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
$23,333
+66,666 vol $0.35 each |
||
Filed 2020-01-02 07:43 Tx date 2019-12-31 |
$PMN
ProMIS Neurosciences Inc. |
Goldstein, Elliot Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$13,333
+66,666 vol $0.20 each |
||
Filed 2020-01-02 07:31 Tx date 2019-12-31 |
$PMN
ProMIS Neurosciences Inc. |
Goldstein, Elliot Paul
4 - Director of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
$23,333
+66,666 vol $0.35 each |
||
Filed 2020-01-02 07:30 Tx date 2019-12-31 |
$PMN
ProMIS Neurosciences Inc. |
Goldstein, Elliot Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$13,333
+66,666 vol $0.20 each |
||
Filed 2019-01-23 Tx date 2019-01-22 |
$PMN
ProMIS Neurosciences Inc. |
Goldstein, Elliot Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$26,589
+115,607 vol $0.23 each |
7,132,900 | |
Filed 2019-01-23 Tx date 2019-01-22 |
$PMN
ProMIS Neurosciences Inc. |
Goldstein, Elliot Paul
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$55,491
+115,607 vol $0.48 each |
371,440 | |
Filed 2018-08-07 Tx date 2018-08-07 |
$PMN
ProMIS Neurosciences Inc. |
Goldstein, Elliot Paul
4 - Director of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$-21,238.20
-106,191 vol $0.20 each |
255,833 | |
Filed 2018-08-07 Tx date 2018-08-07 |
$PMN
ProMIS Neurosciences Inc. |
Goldstein, Elliot Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$21,238
+106,191 vol $0.20 each |
7,017,293 | |
Filed 2018-05-01 Tx date 2018-04-30 |
$PMN
ProMIS Neurosciences Inc. |
Goldstein, Elliot Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$24,999
+66,666 vol $0.375 each |
6,911,102 | |
Filed 2018-05-01 Tx date 2018-04-30 |
$PMN
ProMIS Neurosciences Inc. |
Goldstein, Elliot Paul
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$15,999
+33,333 vol $0.48 each |
362,024 | |
Filed 2018-04-03 Tx date 2018-03-29 |
$PMN
ProMIS Neurosciences Inc. |
Goldstein, Elliot Paul
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$470,000
+1,000,000 vol $0.47 each |
7,948,583 | |
Filed 2017-08-11 Tx date 2017-08-09 |
$PMN
ProMIS Neurosciences Inc. |
Goldstein, Elliot Paul
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$15,000
+50,000 vol $0.30 each |
||
Filed 2017-08-11 Tx date 2017-08-09 |
$PMN
ProMIS Neurosciences Inc. |
Goldstein, Elliot Paul
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+50,000 vol |
328,691 | |
Filed 2017-08-11 Tx date 2017-08-09 |
$PMN
ProMIS Neurosciences Inc. |
Goldstein, Elliot Paul
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$15,000
+50,000 vol $0.30 each |
||
Filed 2017-08-11 Tx date 2017-08-09 |
$PMN
ProMIS Neurosciences Inc. |
Goldstein, Elliot Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$25,000
+100,000 vol $0.25 each |
6,844,436 | |
Filed 2017-02-23 Tx date 2017-02-10 |
$PMN
ProMIS Neurosciences Inc. |
Goldstein, Elliot Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$50,025
+345,000 vol $0.145 each |
6,744,436 | |
Filed 2017-02-23 Tx date 2017-02-10 |
$PMN
ProMIS Neurosciences Inc. |
Goldstein, Elliot Paul
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+172,500 vol |
278,691 | |
Filed 2016-08-11 Tx date 2016-08-10 |
$PMN
ProMIS Neurosciences Inc. |
Goldstein, Elliot Paul
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+106,191 vol |
106,191 | |
Filed 2016-08-11 Tx date 2014-09-04 |
$PMN
ProMIS Neurosciences Inc. |
Goldstein, Elliot Paul
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2016-08-11 Tx date 2016-08-10 |
$PMN
ProMIS Neurosciences Inc. |
Goldstein, Elliot Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$57,343
+424,763 vol $0.135 each |
6,399,436 | |
Filed 2016-05-05 Tx date 2016-05-04 |
$PMN
ProMIS Neurosciences Inc. |
Goldstein, Elliot Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$128,790
+2,146,514 vol $0.06 each |
5,974,673 | |
Filed 2016-03-30 Tx date 2016-03-29 |
$PMN
ProMIS Neurosciences Inc. |
Goldstein, Elliot Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$85,689
+1,428,159 vol $0.06 each |
3,828,159 | |
Filed 2015-08-04 Tx date 2015-07-31 |
$AMF
ProMIS Neurosciences Inc. |
Goldstein, Elliot Paul
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$144,253
+2,219,283 vol $0.065 each |
6,948,583 | |
Filed 2015-08-04 Tx date 2015-07-31 |
$AMF
ProMIS Neurosciences Inc. |
Goldstein, Elliot Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$12,000
+400,000 vol $0.03 each |
2,400,000 | |
Filed 2015-07-13 Tx date 2015-07-06 |
$AMF
Amorfix Life Sciences Ltd. |
Goldstein, Elliot Paul
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$191,536
+4,729,300 vol $0.0405 each |
4,729,300 | |
Filed 2015-07-13 Tx date 2014-09-04 |
$AMF
Amorfix Life Sciences Ltd. |
Goldstein, Elliot Paul
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2015-07-13 Tx date 2015-07-06 |
$AMF
Amorfix Life Sciences Ltd. |
Goldstein, Elliot Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$60,000
+2,000,000 vol $0.03 each |
2,000,000 | |
Filed 2015-07-13 Tx date 2014-09-04 |
$AMF
Amorfix Life Sciences Ltd. |
Goldstein, Elliot Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|